• Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
  • Facebook
  • Twitter
The Wall Street Analyzer

  • Featured Interviews
  • CEO Interviews
  • News Feed
  • Spotlight
  • Sectors
    • Biotech
    • Cannabis
    • Consumer
    • Energy
    • Healthcare
    • Market News
    • Technology
Latest News
  • [ February 2, 2023 ] XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease News Feed
  • [ January 31, 2023 ] Zerify Starts The Year Off Strong News Feed
  • [ January 26, 2023 ] SCOTTIE RESOURCES INTERCEPTS 34.5 G/T GOLD OVER 4.7 METRES ON BLUEBERRY CONTACT ZONE News Feed
  • [ January 24, 2023 ] Zomedica to Participate in the Lytham Partners Investor Select Conference News Feed
  • [ January 23, 2023 ] XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial News Feed
  • [ January 18, 2023 ] Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies News Feed
  • [ January 17, 2023 ] SCOTTIE RESOURCES ANNOUNCES BOARD APPOINTMENT OF ELLIE OWENS News Feed
Home2017

Year: 2017

No Picture
CEO Interviews

Phoenix New Media Ltd (NYSE: FENG) Management Interview

December 19, 2017 The Wall Street Analyzer Comments Off on Phoenix New Media Ltd (NYSE: FENG) Management Interview

Interview with Betty Ho, CFO […]

No Picture
News Feed

TapImmune Announces Enrollment of First Patient in Phase 2 Clinical Trial for Treating Triple-Negative Breast Cancer Funded by U.S. Department of Defense

December 13, 2017 The Wall Street Analyzer Comments Off on TapImmune Announces Enrollment of First Patient in Phase 2 Clinical Trial for Treating Triple-Negative Breast Cancer Funded by U.S. Department of Defense

The randomized trial is sponsored by the Mayo Clinic […]

No Picture
CEO Interviews

Deciphera Pharmaceuticals (NASDAQ: DCPH) CEO Interview

December 11, 2017 The Wall Street Analyzer Comments Off on Deciphera Pharmaceuticals (NASDAQ: DCPH) CEO Interview

Interview with CEO Michael Taylor […]

No Picture
CEO Interviews

ImmuCell Corp (NASDAQ: ICCC) CEO Interview

December 7, 2017 The Wall Street Analyzer Comments Off on ImmuCell Corp (NASDAQ: ICCC) CEO Interview

Interview with CEO Michael Briham […]

CEO Interviews

Trecora Resources (NYSE: TREC) Management Interview Update

December 7, 2017 The Wall Street Analyzer Comments Off on Trecora Resources (NYSE: TREC) Management Interview Update

Interview with Nick Carter, Chairman […]

No Picture
CEO Interviews

TapImmune (NASDAQ: TPIV) CEO Interview

December 1, 2017 The Wall Street Analyzer Comments Off on TapImmune (NASDAQ: TPIV) CEO Interview

Interview with CEO Peter Hoang […]

No Picture
CEO Interviews

Iron Bridge Resources (TSX: IBR) CEO Interview

November 30, 2017 The Wall Street Analyzer Comments Off on Iron Bridge Resources (TSX: IBR) CEO Interview

interview with CEO Robert Colcleugh […]

No Picture
CEO Interviews

Roxgold Inc. (TSX: ROXG) (OTC: ROGFF) CEO Interview

November 22, 2017 The Wall Street Analyzer Comments Off on Roxgold Inc. (TSX: ROXG) (OTC: ROGFF) CEO Interview

Interview with CEO John Dorward […]

No Picture
CEO Interviews

Primo Water (Nasdaq:PRMW) CEO interview

November 21, 2017 The Wall Street Analyzer Comments Off on Primo Water (Nasdaq:PRMW) CEO interview

Interview with CEO Matt Sheehan […]

No Picture
CEO Interviews

Creative Realities Inc (OTCQX: CREX) CEO Interview

November 21, 2017 The Wall Street Analyzer Comments Off on Creative Realities Inc (OTCQX: CREX) CEO Interview

Interview with CEO Rick Mills […]

Posts navigation

1 2 … 19 »

Featured Companies

CEO Interviews

Zomedica Corp. (NYSE American: ZOM)

November 29, 2022 0

Interview update with Larry Heaton, CEO and President […]

CEO Interviews

Acutus Medical (NASDAQ: AFIB)

November 19, 2022 0

Interview with David Roman, CEO […]

Featured Interviews

Zerify (OTCQB: ZRFY)

November 18, 2022 0

Interview with Mark Kay, CEO and Chairman […]

Featured Interviews

Xortx Therapeutics (CSE: XRX) (NASDAQ: XRTF)

October 25, 2022 0

Interview update with Dr. Allen Davidoff, CEO
[…]

CEO Interviews

Pro-Dex, Inc (NASDAQ: PDEX) CEO Interview Update

October 24, 2022 0

Interview with Rick Van Kirk, CEO […]

News Wire

  • XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease
    February 2, 2023 0
  • Zerify Starts The Year Off Strong
    January 31, 2023 0
  • SCOTTIE RESOURCES INTERCEPTS 34.5 G/T GOLD OVER 4.7 METRES ON BLUEBERRY CONTACT ZONE
    January 26, 2023 0
  • Zomedica to Participate in the Lytham Partners Investor Select Conference
    January 24, 2023 0
  • XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial
    January 23, 2023 0
  • Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies
    January 18, 2023 0
  • SCOTTIE RESOURCES ANNOUNCES BOARD APPOINTMENT OF ELLIE OWENS
    January 17, 2023 0




Follow on Facebook

About Us

The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
Quick links
  • Home
  • About
  • Press
  • Services
  • Legal
  • Payment
  • Contact
Stay connected
  • Facebook
  • Twitter
Recent Case Study
Biotech

Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

August 12, 2019 Comments Off on Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

About Co-Diagnostics, Inc: Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection […]

Testimonials
Testimonials

Client Testimonials:

June 1, 2020 Comments Off on Client Testimonials:

“What we like most about the wallstreetanalyzer.com was their service consistently brought Marifil Mines Ltd new viewers to our company.  The interviews are high quality, to the point, friendly and enlightening.  We have been using his […]

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com